This handout is for stemi / omi (acute coronary syndrome). Your care team identified this based on: ischemic chest pain / anginal equivalent (acc/aha 2025 class i).
Other reasons your team may use this plan: ecg stemi / omi / sgarbossa+ / de winter / wellens (esc 2023; sgarbossa nejm 1996; de winter nejm 2008); rising troponin in ischemic context (4th universal definition of mi 2018); post-arrest rosc with ischemic ecg (acc/aha 2025 class i).
Take these medications exactly as prescribed. Do not stop or change a dose without talking to your provider.
| Medication | Starting dose | How | When | What it does |
|---|---|---|---|---|
| aspirin | 162–325 mg chewed | PO | once now then 81 mg daily | 2025 ACC/AHA Class I — chewed non-enteric ASA at first medical contact |
| ticagrelor | 180 mg load | PO | once now then 90 mg BID × 12 mo | PLATO 2009 — preferred over clopidogrel for primary PCI per ACC/AHA 2025 Class I; AVOID with prior ICH |
| prasugrel | 60 mg load | PO | once now then 10 mg daily × 12 mo (5 mg if <60 kg or ≥75 yo) | TRITON-TIMI 38 2007 — preferred in PCI-eligible without stroke history per ACC/AHA 2025 Class I |
| clopidogrel | 600 mg load (PCI) or 300 mg (lytic) | PO | once now then 75 mg daily × 12 mo | CLARITY-TIMI 28 — default if ticagrelor/prasugrel contraindicated; standard with fibrinolysis per ACC/AHA 2025 Class I |
| nitroglycerin | 0.4 mg SL q5min × 3 → IV 5–10 µg/min titrated | SL/IV | PRN ischemic pain; continuous IV if HF/HTN | ACC/AHA 2025 Class III — AVOID if RV infarct, SBP <90, or PDE5 inhibitor in last 24–48 h |
| morphine | 2–4 mg IV | IV | q5–15 min PRN | ACC/AHA 2025 Class IIb — reserve for ongoing pain; may slow P2Y12 absorption (CRUSADE registry) |
Plan: STEMI acute — reperfusion + adjunctive antiplatelet/anticoagulant/anti-ischemic per ACC/AHA 2025
Contact your care team if any of the following happen:
Call 911 or go to the nearest emergency room right away if you have:
Guideline: 2025 ACC/AHA/ACEP/NAEMSP/SCAI ACS Guideline + 2023 ESC ACS Guidelines